PharmiWeb.com - Global Pharma News & Resources
09-Feb-2024

Global Oscillating Positive Expiratory Pressure (OPEP) Devices Market, with projections indicating US$ 195.2 Million by 2029 | FMI

Oscillating Positive Expiratory Pressure (OPEP) Devices Market

The global oscillating positive expiratory pressure (OPEP) devices market is poised for remarkable growth, reaching an estimated value of US$ 135.9 Million in 2022 and projecting to surge to US$ 195.2 million by 2029. This significant uptrend represents a Compound Annual Growth Rate (CAGR) of 5.3% over the forecast period, according to a recent industry analysis.

A comprehensive study indicates that the global market for OPEP devices is set to experience substantial development, driven by multiple factors, with increased availability at the regional level playing a pivotal role. The manufacturer-led innovation in device design and the growing adoption of OPEP devices among patients with respiratory disorders are key contributors to the optimistic growth outlook.

Discover Our Expert Analysis with Our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-3397

“Our commitment to advancing respiratory care solutions aligns with the industry’s positive outlook. We are dedicated to driving innovation in device design and expanding the availability of OPEP devices at the regional level. As the market continues to grow, we are well-positioned to meet the evolving needs of patients and healthcare professionals globally,” said Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

The anticipated surge in the global OPEP devices market not only signifies industry growth but also highlights the importance of respiratory care in healthcare ecosystems worldwide. FMI is poised to play a pivotal role in this expansion by continuing to deliver cutting-edge solutions and fostering accessibility to respiratory care on a broader scale.

Mouthpiece OPEP Devices – Preferred Choice for Airway Clearance:

Based on the analysis of OPEP devices market by product, mouthpiece oscillating positive expiratory pressure devices are expected to hold a prominent value share in the global market. This, according to FMI’s analysis, has majorly resulted from the ease of use of these devices as well as comparatively wider availability in the market.

On the other side, based on indication, the COPD is likely to consume a majority share of the oscillating positive expiratory pressure devices market value. This is majorly due to the higher prevalence of the disease and adoption of oscillating positive expiratory pressure devices for disease management. Although, cystic fibrosis is rare disease and has limited patient pool yet adoption of oscillating positive expiratory pressure devices remains highest in cystic fibrosis patients.

Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-3397

OPEP Devices Market: Vendor Insights:

The report highlights some of the prominent market players, who have established themselves as leaders in the global oscillating positive expiratory pressure devices market. Some of the prominent key players in the global OPEP devices market are:

  • Smiths Medical, Inc.
  • Allergan plc
  • Monaghan Medical Corporation & Trudell Medical International
  • Others
  • PARI GmbH
  • WyMedical Pty Ltd
  • R. Cegla GmbH & Co. KG
  • D-R BURTON HEALTHCARE
  • AirPhysio
  • Medica Holdings, LLC.

The global oscillating positive expiratory pressure devices market is significantly consolidated, with top two players holding prominent shares in the market revenues. These players are offering oscillating positive expiratory pressure devices under their popular brands such as Portex®, Flutter®, and Aerobika®, among others.

Oscillating Positive Expiratory Pressure (OPEP) Devices Market by Category:

By Product Type:

  • Face Mask PEP Devices
  • Mouthpiece PEP Devices
  • Bottle PEP Devices

By Indication:

  • COPD
  • Asthma
  • Atelectasis
  • Bronchitis
  • Bronchiectasis
  • Cystic Fibrosis
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Personalized Experiences Redefined: Our Customization Report Holds the Answers! https://www.futuremarketinsights.com/customization-available/rep-gb-3397

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 09-Feb-2024